These results support that UBQLN4 is a key factor to maintain an important balance of DDR and thus, elevated UBQLN4 mRNA levels determined resistance to cisplatin, while improving PARPi sensitivity in cancer cell lines. Here, UBQLN4 is linked to cancer.